Tony

/Tony Bico

About Tony Bico

This author has not yet filled in any details.
So far has created 17 blog entries.

HIV Vaccine Developed Through Centers Collaboration: Moving towards human clinical trials

Over the past 6 years, Dr. Peter Barry’s lab at the Center for Comparative Medicine has been collaborating with Dr. Louis Picker and colleagues at the Oregon Health Science University (OHSU) to optimize a novel HIV vaccine.  The vaccine stems directly from research in Dr. Barry’s lab that has focused on the rhesus macaque model […]

Dr. Nicole Baumgarth received 5-year grant from the National Institute of Allergy and Infectious Diseases (NIAID)

Congratulations Dr. Baumgarth!  Dr. Nicole Baumgarth just received a five year grant from the National Institute of Allergy and Infectious Diseases (NIAID) division of NIH to study “Protective Humoral Immunity to Influenza Infection” (R01AI117890).  Antibody-mediated immunity generated by B lymphocytes is important for immune protection from infections. We are investigating a particular type of B […]

Murray B. Gardner Junior Faculty Research Fellowship in Infectious Disease, 2016-17

The Junior Faculty Research Fellow in Infectious Disease is in its inaugural year, 2016. The fellowship supports junior faculty performing research in Animal Modeling of Human Diseases with a focus on infectious disease or pathogen-host interactions. The goal of this program is to enable career advancement of junior faculty to the Associate Professor level by […]

Dr. Nicole Baumgarth awarded a Steven & Alexandra Cohen Foundation research award.

Dr. Nicole Baumgarth was recently awarded a Steven & Alexandra Cohen Foundation research award, “Reversing Borrelia burgdorferi-induced immune suppression with novel immunotherapies”.  A functioning immune system is indispensable for protection from infections and for supporting treatments designed to clear infections and resolve disease symptoms.  Dr. Baumgarth proposes to test their hypothesis that B. […]

MBP designated as one of the first UC Davis Campus Research Core Facilities

We are happy to announce that the Mouse Biology Program (MBP) is one of the 17 cores selected to receive designation as a UC Davis Campus Research Core Facility under the Research Core Facilities Program.  The mission of the Research Core Facilities Program is to enable researchers at UC Davis to have access to the […]

Jay V. Solnick, MD, PhD, Elected Fellow of the American Academy of Microbiology

Dr. Jay V. Solnick was elected a Fellow of the American Academy of Microbiology. This award is conferred by the American Society for Microbiology and election to this Academy recognizes scientists for having made “outstanding contributions to the field of Microbiology”. Congratulations Dr. Solnick!

CD4 T cell responses to Chlamydia infection

Dr. Stephen McSorley was recently awarded a National Institutes of Health grant to study “CD4 T cell responses to Chlamydia infection” through the National Institutes of Allergy and Infectious Diseases (R01AI103422).  The  CDC estimates that Chlamydia is one of the most prevalent bacterial infections in the US and causes upper reproductive tract pathology in a […]

13 UC Davis Discoveries That Changed Our World

Our very own Dr. Murray B. Gardner was one of the researchers mentioned in the article “13 UC Davis Discoveries That Changed Our World” listed as no. 8 under Biomedical Sciences and Medicine section. Murray Gardner and his colleagues in the Medical and Veterinary Schools were able to isolate the retroviruses that caused fatal immunodeficiency […]

Dr. Peter A. Barry, Elected AAAS Fellow

It is a great pleasure to announce to everyone that Peter Barry has been elected a fellow of the American Association for the Advancement of Science. This is a major honor since it represents a recognition from the scientific community of significant advances made by an individual in their scientific career to date. This particular […]

CRISPR Based Genome Editing Service

The UC Davis Mouse Biology Program (MBP) is happy to announce CRISPR-based genome editing (InDel, Exon Deletion ) in murine embryonic stem (ES) cells and zygotes as a service for the academic scientific community.